Emerging retatrutide, a combined-action treatment targeting simultaneously GLP-1 and GIP receptors, is sparking considerable interest within the medical community. Initial clinical research have revealed impressive reductions in body weight and advancements in health markers for patients with overweight. Researchers believe this novel approach m… Read More